nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—TCN1—exocrine gland—cervical cancer	0.0286	0.0571	CbGeAlD
Hydroxocobalamin—Cyanocobalamin—MTHFR—cervical cancer	0.0227	1	CrCbGaD
Hydroxocobalamin—AMN—uterine cervix—cervical cancer	0.0162	0.0325	CbGeAlD
Hydroxocobalamin—Bullous eruption—Topotecan—cervical cancer	0.0161	0.146	CcSEcCtD
Hydroxocobalamin—AMN—renal system—cervical cancer	0.0152	0.0304	CbGeAlD
Hydroxocobalamin—CUBN—epithelium—cervical cancer	0.0138	0.0276	CbGeAlD
Hydroxocobalamin—CUBN—renal system—cervical cancer	0.0128	0.0256	CbGeAlD
Hydroxocobalamin—TCN1—uterine cervix—cervical cancer	0.0123	0.0246	CbGeAlD
Hydroxocobalamin—TCN1—decidua—cervical cancer	0.0117	0.0235	CbGeAlD
Hydroxocobalamin—TCN1—endometrium—cervical cancer	0.0111	0.0223	CbGeAlD
Hydroxocobalamin—CASP9—decidua—cervical cancer	0.0108	0.0216	CbGeAlD
Hydroxocobalamin—TCN1—mammalian vulva—cervical cancer	0.0108	0.0215	CbGeAlD
Hydroxocobalamin—CASP9—renal system—cervical cancer	0.0106	0.0212	CbGeAlD
Hydroxocobalamin—TCN2—decidua—cervical cancer	0.0105	0.0211	CbGeAlD
Hydroxocobalamin—TCN2—renal system—cervical cancer	0.0103	0.0207	CbGeAlD
Hydroxocobalamin—CUBN—female reproductive system—cervical cancer	0.0102	0.0205	CbGeAlD
Hydroxocobalamin—CUBN—female gonad—cervical cancer	0.00932	0.0187	CbGeAlD
Hydroxocobalamin—MMAB—female reproductive system—cervical cancer	0.00909	0.0182	CbGeAlD
Hydroxocobalamin—Lung disorder—Topotecan—cervical cancer	0.00897	0.0814	CcSEcCtD
Hydroxocobalamin—MMAA—female gonad—cervical cancer	0.00882	0.0176	CbGeAlD
Hydroxocobalamin—MMAA—vagina—cervical cancer	0.00876	0.0175	CbGeAlD
Hydroxocobalamin—MUT—uterine cervix—cervical cancer	0.0087	0.0174	CbGeAlD
Hydroxocobalamin—CASP9—female reproductive system—cervical cancer	0.00849	0.017	CbGeAlD
Hydroxocobalamin—TCN1—vagina—cervical cancer	0.00834	0.0167	CbGeAlD
Hydroxocobalamin—Pleural effusion—Topotecan—cervical cancer	0.00829	0.0752	CcSEcCtD
Hydroxocobalamin—TCN2—female reproductive system—cervical cancer	0.00829	0.0166	CbGeAlD
Hydroxocobalamin—MUT—decidua—cervical cancer	0.00829	0.0166	CbGeAlD
Hydroxocobalamin—MMAB—female gonad—cervical cancer	0.00827	0.0165	CbGeAlD
Hydroxocobalamin—MMAB—vagina—cervical cancer	0.00822	0.0164	CbGeAlD
Hydroxocobalamin—MUT—renal system—cervical cancer	0.00814	0.0163	CbGeAlD
Hydroxocobalamin—MUT—endometrium—cervical cancer	0.00787	0.0157	CbGeAlD
Hydroxocobalamin—MTRR—uterine cervix—cervical cancer	0.00782	0.0156	CbGeAlD
Hydroxocobalamin—CASP9—female gonad—cervical cancer	0.00773	0.0155	CbGeAlD
Hydroxocobalamin—CASP9—vagina—cervical cancer	0.00768	0.0154	CbGeAlD
Hydroxocobalamin—MUT—mammalian vulva—cervical cancer	0.00761	0.0152	CbGeAlD
Hydroxocobalamin—MTRR—decidua—cervical cancer	0.00745	0.0149	CbGeAlD
Hydroxocobalamin—MTRR—renal system—cervical cancer	0.00731	0.0146	CbGeAlD
Hydroxocobalamin—Extravasation—Topotecan—cervical cancer	0.00728	0.066	CcSEcCtD
Hydroxocobalamin—MUT—uterus—cervical cancer	0.00725	0.0145	CbGeAlD
Hydroxocobalamin—AMN—lymph node—cervical cancer	0.00712	0.0142	CbGeAlD
Hydroxocobalamin—MTRR—endometrium—cervical cancer	0.00707	0.0141	CbGeAlD
Hydroxocobalamin—MTRR—mammalian vulva—cervical cancer	0.00684	0.0137	CbGeAlD
Hydroxocobalamin—MTR—uterine cervix—cervical cancer	0.00682	0.0136	CbGeAlD
Hydroxocobalamin—MUT—female reproductive system—cervical cancer	0.00652	0.013	CbGeAlD
Hydroxocobalamin—MTRR—uterus—cervical cancer	0.00651	0.013	CbGeAlD
Hydroxocobalamin—MTR—decidua—cervical cancer	0.0065	0.013	CbGeAlD
Hydroxocobalamin—MTR—renal system—cervical cancer	0.00638	0.0128	CbGeAlD
Hydroxocobalamin—MTR—endometrium—cervical cancer	0.00617	0.0123	CbGeAlD
Hydroxocobalamin—CUBN—lymph node—cervical cancer	0.00599	0.012	CbGeAlD
Hydroxocobalamin—MTR—mammalian vulva—cervical cancer	0.00596	0.0119	CbGeAlD
Hydroxocobalamin—MUT—female gonad—cervical cancer	0.00593	0.0119	CbGeAlD
Hydroxocobalamin—MUT—vagina—cervical cancer	0.00589	0.0118	CbGeAlD
Hydroxocobalamin—MTRR—female reproductive system—cervical cancer	0.00586	0.0117	CbGeAlD
Hydroxocobalamin—MTR—uterus—cervical cancer	0.00568	0.0114	CbGeAlD
Hydroxocobalamin—MMAA—lymph node—cervical cancer	0.00567	0.0113	CbGeAlD
Hydroxocobalamin—MTRR—female gonad—cervical cancer	0.00533	0.0107	CbGeAlD
Hydroxocobalamin—MMAB—lymph node—cervical cancer	0.00532	0.0106	CbGeAlD
Hydroxocobalamin—MTRR—vagina—cervical cancer	0.0053	0.0106	CbGeAlD
Hydroxocobalamin—MTR—female reproductive system—cervical cancer	0.00511	0.0102	CbGeAlD
Hydroxocobalamin—CASP9—lymph node—cervical cancer	0.00497	0.00994	CbGeAlD
Hydroxocobalamin—TCN2—lymph node—cervical cancer	0.00485	0.0097	CbGeAlD
Hydroxocobalamin—Dermatitis bullous—Topotecan—cervical cancer	0.00482	0.0438	CcSEcCtD
Hydroxocobalamin—MTR—female gonad—cervical cancer	0.00465	0.0093	CbGeAlD
Hydroxocobalamin—MTR—vagina—cervical cancer	0.00462	0.00924	CbGeAlD
Hydroxocobalamin—Cardiac arrest—Topotecan—cervical cancer	0.00438	0.0398	CcSEcCtD
Hydroxocobalamin—MUT—lymph node—cervical cancer	0.00381	0.00763	CbGeAlD
Hydroxocobalamin—MTRR—lymph node—cervical cancer	0.00343	0.00685	CbGeAlD
Hydroxocobalamin—MTR—lymph node—cervical cancer	0.00299	0.00598	CbGeAlD
Hydroxocobalamin—Angiopathy—Topotecan—cervical cancer	0.00289	0.0262	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Topotecan—cervical cancer	0.00288	0.0261	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Topotecan—cervical cancer	0.00287	0.0261	CcSEcCtD
Hydroxocobalamin—Chills—Topotecan—cervical cancer	0.00286	0.026	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Topotecan—cervical cancer	0.00258	0.0234	CcSEcCtD
Hydroxocobalamin—Angioedema—Topotecan—cervical cancer	0.00254	0.023	CcSEcCtD
Hydroxocobalamin—Malaise—Topotecan—cervical cancer	0.0025	0.0227	CcSEcCtD
Hydroxocobalamin—Chest pain—Topotecan—cervical cancer	0.00236	0.0214	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00235	0.0213	CcSEcCtD
Hydroxocobalamin—Discomfort—Topotecan—cervical cancer	0.00233	0.0212	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Topotecan—cervical cancer	0.00227	0.0206	CcSEcCtD
Hydroxocobalamin—Infection—Topotecan—cervical cancer	0.00225	0.0204	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Topotecan—cervical cancer	0.00222	0.0202	CcSEcCtD
Hydroxocobalamin—Skin disorder—Topotecan—cervical cancer	0.0022	0.02	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Topotecan—cervical cancer	0.00202	0.0183	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Topotecan—cervical cancer	0.00199	0.0181	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Topotecan—cervical cancer	0.00196	0.0177	CcSEcCtD
Hydroxocobalamin—Pain—Topotecan—cervical cancer	0.00194	0.0176	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Topotecan—cervical cancer	0.00187	0.0169	CcSEcCtD
Hydroxocobalamin—Urticaria—Topotecan—cervical cancer	0.0018	0.0163	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Topotecan—cervical cancer	0.00179	0.0162	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Topotecan—cervical cancer	0.00167	0.0151	CcSEcCtD
Hydroxocobalamin—Pruritus—Topotecan—cervical cancer	0.0016	0.0145	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Topotecan—cervical cancer	0.00155	0.0141	CcSEcCtD
Hydroxocobalamin—Dizziness—Topotecan—cervical cancer	0.0015	0.0136	CcSEcCtD
Hydroxocobalamin—Rash—Topotecan—cervical cancer	0.00143	0.013	CcSEcCtD
Hydroxocobalamin—Dermatitis—Topotecan—cervical cancer	0.00143	0.0129	CcSEcCtD
Hydroxocobalamin—Headache—Topotecan—cervical cancer	0.00142	0.0129	CcSEcCtD
Hydroxocobalamin—Nausea—Topotecan—cervical cancer	0.00135	0.0122	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—FGFR3—cervical cancer	0.000843	0.0023	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—FGFR3—cervical cancer	0.000843	0.0023	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—FGFR3—cervical cancer	0.000835	0.00228	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—FGFR3—cervical cancer	0.000828	0.00226	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—FGFR3—cervical cancer	0.000824	0.00225	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.000818	0.00223	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—WNT5A—cervical cancer	0.000818	0.00223	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—WNT2—cervical cancer	0.000818	0.00223	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—CASP8—cervical cancer	0.000801	0.00218	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—CA9—cervical cancer	0.000788	0.00215	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—FGFR3—cervical cancer	0.00078	0.00212	CbGpPWpGaD
Hydroxocobalamin—CASP9—Rac1/Pak1/p38/MMP-2 pathway—TP53—cervical cancer	0.000761	0.00207	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—WNT5A—cervical cancer	0.000755	0.00206	CbGpPWpGaD
Hydroxocobalamin—CASP9—DNA Damage Response—TP53—cervical cancer	0.000752	0.00205	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—CASP8—cervical cancer	0.000751	0.00205	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—FGFR3—cervical cancer	0.000746	0.00203	CbGpPWpGaD
Hydroxocobalamin—CASP9—p75(NTR)-mediated signaling—TP53—cervical cancer	0.000743	0.00202	CbGpPWpGaD
Hydroxocobalamin—CASP9—Constitutive PI3K/AKT Signaling in Cancer—EGFR—cervical cancer	0.000742	0.00202	CbGpPWpGaD
Hydroxocobalamin—CASP9—miRNA Regulation of DNA Damage Response—TP53—cervical cancer	0.000726	0.00198	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—MTOR—cervical cancer	0.000711	0.00194	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—MTOR—cervical cancer	0.00068	0.00185	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000678	0.00185	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.000673	0.00183	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—MTOR—cervical cancer	0.00067	0.00182	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI-3K cascade—EGFR—cervical cancer	0.000668	0.00182	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—WNT2—cervical cancer	0.000667	0.00182	CbGpPWpGaD
Hydroxocobalamin—CASP9—Alzheimers Disease—TP53—cervical cancer	0.000667	0.00182	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI3K/AKT activation—EGFR—cervical cancer	0.000652	0.00178	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—HES1—cervical cancer	0.000651	0.00177	CbGpPWpGaD
Hydroxocobalamin—CASP9—GAB1 signalosome—EGFR—cervical cancer	0.000647	0.00176	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CA9—cervical cancer	0.000647	0.00176	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—MTOR—cervical cancer	0.00064	0.00174	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—MTOR—cervical cancer	0.000636	0.00173	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TP53—cervical cancer	0.000635	0.00173	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—MTOR—cervical cancer	0.000633	0.00173	CbGpPWpGaD
Hydroxocobalamin—CASP9—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—cervical cancer	0.000632	0.00172	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—MTOR—cervical cancer	0.00063	0.00172	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—MTOR—cervical cancer	0.000621	0.00169	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—WNT5A—cervical cancer	0.00062	0.00169	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.000619	0.00169	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—CASP3—cervical cancer	0.000606	0.00165	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.000597	0.00163	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—HES1—cervical cancer	0.000596	0.00162	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—HES1—cervical cancer	0.000596	0.00162	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—TP53—cervical cancer	0.000595	0.00162	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—MTOR—cervical cancer	0.000593	0.00162	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—MTOR—cervical cancer	0.000593	0.00162	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—MTOR—cervical cancer	0.000593	0.00162	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—MTOR—cervical cancer	0.000588	0.0016	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—CTNNB1—cervical cancer	0.000585	0.00159	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—MTOR—cervical cancer	0.000582	0.00159	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—MTOR—cervical cancer	0.00058	0.00158	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—FGFR3—cervical cancer	0.000574	0.00156	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—MTHFR—cervical cancer	0.000572	0.00156	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—TERT—cervical cancer	0.000571	0.00155	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—CASP3—cervical cancer	0.000569	0.00155	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—HES1—cervical cancer	0.000554	0.00151	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—STAT3—cervical cancer	0.00055	0.0015	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—MTOR—cervical cancer	0.000549	0.00149	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—UBE3A—cervical cancer	0.000536	0.00146	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CA9—cervical cancer	0.000527	0.00144	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HLA-DPB1—cervical cancer	0.000527	0.00144	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—MTOR—cervical cancer	0.000525	0.00143	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—FGFR3—cervical cancer	0.000524	0.00143	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—MTHFR—cervical cancer	0.000523	0.00143	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—MTHFR—cervical cancer	0.000523	0.00143	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—TERT—cervical cancer	0.000522	0.00142	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—TERT—cervical cancer	0.000522	0.00142	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000513	0.0014	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—WNT5A—cervical cancer	0.000505	0.00138	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—WNT2—cervical cancer	0.000502	0.00137	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—EGFR—cervical cancer	0.0005	0.00136	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000495	0.00135	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—STAT3—cervical cancer	0.000494	0.00135	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HES1—cervical cancer	0.000494	0.00134	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HES1—cervical cancer	0.000494	0.00134	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—NOTCH1—cervical cancer	0.000492	0.00134	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MTHFR—cervical cancer	0.000487	0.00133	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—TERT—cervical cancer	0.000485	0.00132	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—MTHFR—cervical cancer	0.000479	0.00131	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—FGFR3—cervical cancer	0.000479	0.0013	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—FGFR3—cervical cancer	0.000479	0.0013	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—EGFR—cervical cancer	0.000478	0.0013	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.000473	0.00129	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HES1—cervical cancer	0.000471	0.00128	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—EGFR—cervical cancer	0.00047	0.00128	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—STAT3—cervical cancer	0.000458	0.00125	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TAAR6—cervical cancer	0.00045	0.00123	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—NOTCH1—cervical cancer	0.00045	0.00122	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—NOTCH1—cervical cancer	0.00045	0.00122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—EGFR—cervical cancer	0.000449	0.00122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—STAT3—cervical cancer	0.000448	0.00122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—EGFR—cervical cancer	0.000447	0.00122	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—FGFR3—cervical cancer	0.000445	0.00121	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—EGFR—cervical cancer	0.000445	0.00121	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—EGFR—cervical cancer	0.000443	0.00121	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—MTHFR—cervical cancer	0.000438	0.00119	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—MTHFR—cervical cancer	0.000438	0.00119	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—EGFR—cervical cancer	0.000436	0.00119	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—HES1—cervical cancer	0.000435	0.00118	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—EGFR—cervical cancer	0.000434	0.00118	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MTHFR—cervical cancer	0.000434	0.00118	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MTHFR—cervical cancer	0.000434	0.00118	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—TERT—cervical cancer	0.000432	0.00118	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—TERT—cervical cancer	0.000432	0.00118	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—NOTCH1—cervical cancer	0.000418	0.00114	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—EGFR—cervical cancer	0.000416	0.00113	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—EGFR—cervical cancer	0.000416	0.00113	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—EGFR—cervical cancer	0.000416	0.00113	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MTHFR—cervical cancer	0.000414	0.00113	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—EGFR—cervical cancer	0.000413	0.00112	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—TERT—cervical cancer	0.000413	0.00112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HLA-DQB1—cervical cancer	0.000412	0.00112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—EGFR—cervical cancer	0.000409	0.00111	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—MTHFR—cervical cancer	0.000407	0.00111	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—EGFR—cervical cancer	0.000407	0.00111	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	0.000406	0.00111	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—MTOR—cervical cancer	0.000404	0.0011	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.000397	0.00108	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—FGFR3—cervical cancer	0.000397	0.00108	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—FGFR3—cervical cancer	0.000397	0.00108	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000392	0.00107	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TP53—cervical cancer	0.000389	0.00106	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—EGFR—cervical cancer	0.000385	0.00105	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD8A—cervical cancer	0.000384	0.00105	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MTHFR—cervical cancer	0.000382	0.00104	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—TERT—cervical cancer	0.000381	0.00104	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—WNT5A—cervical cancer	0.000381	0.00104	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—FGFR3—cervical cancer	0.000379	0.00103	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—NOTCH1—cervical cancer	0.000373	0.00101	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—NOTCH1—cervical cancer	0.000373	0.00101	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—CASP3—cervical cancer	0.000371	0.00101	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	0.000369	0.001	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—MTOR—cervical cancer	0.000368	0.001	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—CD4—cervical cancer	0.000368	0.001	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TP53—cervical cancer	0.000365	0.000993	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—MTHFR—cervical cancer	0.000363	0.000989	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—MTHFR—cervical cancer	0.000363	0.000989	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HES1—cervical cancer	0.000357	0.000972	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—NOTCH1—cervical cancer	0.000355	0.000968	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—WNT2—cervical cancer	0.000352	0.000958	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—FGFR3—cervical cancer	0.000349	0.000952	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—MTHFR—cervical cancer	0.000346	0.000944	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—MTOR—cervical cancer	0.000337	0.000918	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—MTOR—cervical cancer	0.000337	0.000918	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—CD4—cervical cancer	0.000336	0.000916	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—CD4—cervical cancer	0.000336	0.000916	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000329	0.000896	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NOTCH1—cervical cancer	0.000328	0.000894	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—FGFR3—cervical cancer	0.000327	0.000892	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—CTNNB1—cervical cancer	0.000327	0.00089	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-DPB1—cervical cancer	0.00032	0.000871	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—MTHFR—cervical cancer	0.00032	0.000871	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—FGFR3—cervical cancer	0.000314	0.000857	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MTHFR—cervical cancer	0.000314	0.000854	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MTOR—cervical cancer	0.000313	0.000853	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TERT—cervical cancer	0.000313	0.000852	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—CD4—cervical cancer	0.000313	0.000852	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—STAT3—cervical cancer	0.000312	0.00085	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKAP13—cervical cancer	0.000309	0.000841	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—CTNNB1—cervical cancer	0.000299	0.000814	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—CTNNB1—cervical cancer	0.000299	0.000814	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HES1—cervical cancer	0.000291	0.000792	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—FGFR3—cervical cancer	0.000287	0.000782	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—STAT3—cervical cancer	0.000285	0.000776	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—EGFR—cervical cancer	0.000284	0.000773	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CASP8—cervical cancer	0.00028	0.000763	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MTOR—cervical cancer	0.000279	0.000761	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MTOR—cervical cancer	0.000279	0.000761	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CD4—cervical cancer	0.000279	0.000759	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CD4—cervical cancer	0.000279	0.000759	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—CTNNB1—cervical cancer	0.000278	0.000756	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NOTCH1—cervical cancer	0.000269	0.000734	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—WNT5A—cervical cancer	0.000266	0.000726	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MTOR—cervical cancer	0.000266	0.000726	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CD4—cervical cancer	0.000266	0.000724	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—MTHFR—cervical cancer	0.000263	0.000715	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—STAT3—cervical cancer	0.00026	0.000709	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—STAT3—cervical cancer	0.00026	0.000709	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—EGFR—cervical cancer	0.000259	0.000705	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MTHFR—cervical cancer	0.000256	0.000696	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TERT—cervical cancer	0.000255	0.000694	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-DQB1—cervical cancer	0.00025	0.00068	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CTNNB1—cervical cancer	0.000248	0.000674	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CTNNB1—cervical cancer	0.000248	0.000674	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MTOR—cervical cancer	0.000246	0.00067	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CD4—cervical cancer	0.000245	0.000668	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—STAT3—cervical cancer	0.000242	0.000659	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—EGFR—cervical cancer	0.000237	0.000645	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—EGFR—cervical cancer	0.000237	0.000645	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CTNNB1—cervical cancer	0.000236	0.000643	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—FGFR3—cervical cancer	0.000234	0.000637	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD8A—cervical cancer	0.000233	0.000635	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MTOR—cervical cancer	0.00023	0.000628	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CD4—cervical cancer	0.00023	0.000626	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—MTOR—cervical cancer	0.000221	0.000603	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD4—cervical cancer	0.000221	0.000601	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—EGFR—cervical cancer	0.00022	0.000599	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NOTCH1—cervical cancer	0.00022	0.000598	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HES1—cervical cancer	0.000219	0.000597	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CTNNB1—cervical cancer	0.000218	0.000594	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—STAT3—cervical cancer	0.000216	0.000588	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—STAT3—cervical cancer	0.000216	0.000588	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—MTHFR—cervical cancer	0.000214	0.000583	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—STAT3—cervical cancer	0.000206	0.000561	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CTNNB1—cervical cancer	0.000204	0.000556	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MTOR—cervical cancer	0.000202	0.00055	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CD4—cervical cancer	0.000201	0.000549	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—EGFR—cervical cancer	0.000196	0.000534	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—EGFR—cervical cancer	0.000196	0.000534	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MTHFR—cervical cancer	0.000192	0.000524	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TERT—cervical cancer	0.000192	0.000523	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FGFR3—cervical cancer	0.000191	0.00052	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—STAT3—cervical cancer	0.00019	0.000517	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—EGFR—cervical cancer	0.000187	0.00051	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOTCH2—cervical cancer	0.000187	0.000509	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CTNNB1—cervical cancer	0.000179	0.000487	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FGFR3—cervical cancer	0.000176	0.00048	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EGFR—cervical cancer	0.000173	0.00047	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOTCH1—cervical cancer	0.000165	0.00045	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MTOR—cervical cancer	0.000165	0.000448	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CD4—cervical cancer	0.000164	0.000447	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CASP8—cervical cancer	0.000163	0.000444	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EGFR—cervical cancer	0.000162	0.000441	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—STAT3—cervical cancer	0.000156	0.000425	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—EGFR—cervical cancer	0.000155	0.000423	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HES1—cervical cancer	0.000153	0.000418	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CTNNB1—cervical cancer	0.000146	0.000397	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EGFR—cervical cancer	0.000142	0.000386	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TERT—cervical cancer	0.000134	0.000366	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MTOR—cervical cancer	0.000134	0.000365	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD4—cervical cancer	0.000134	0.000365	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—STAT3—cervical cancer	0.000127	0.000346	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MTOR—cervical cancer	0.000124	0.000337	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CD4—cervical cancer	0.000124	0.000337	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGFR3—cervical cancer	0.000123	0.000336	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CTNNB1—cervical cancer	0.000119	0.000324	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOTCH1—cervical cancer	0.000116	0.000315	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EGFR—cervical cancer	0.000116	0.000315	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CTNNB1—cervical cancer	0.00011	0.000299	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—STAT3—cervical cancer	0.000104	0.000282	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—STAT3—cervical cancer	9.57e-05	0.000261	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGFR—cervical cancer	9.42e-05	0.000257	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGFR—cervical cancer	8.7e-05	0.000237	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MTOR—cervical cancer	8.68e-05	0.000236	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CASP3—cervical cancer	7.98e-05	0.000217	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CTNNB1—cervical cancer	7.69e-05	0.00021	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STAT3—cervical cancer	6.7e-05	0.000183	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGFR—cervical cancer	6.09e-05	0.000166	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—cervical cancer	5.12e-05	0.000139	CbGpPWpGaD
